Acumen Pharmaceuticals, Inc. (ABOS) at a glance

Acumen Pharmaceuticals, Inc. (ABOS) is a micro-cap Healthcare company. It trades at $3.13, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 57/100 overall. Its strongest dimension is Safety (80/100) and its weakest is Income (40/100). It is a relatively defensive holding with below-market volatility.

Price

$3.13

Market cap

$171.2M

P/E ratio

n/a

Dividend yield

None

Beta

0.35

52-week range

$1.21 to $3.60